By The Fly
Publication Date: 2026-05-07 13:45:00
The most talked-about and market-moving research calls around Wall Street are now in one place. Here are today’s research calls investors need to know, compiled by The Fly.
Top 5 upgrades:
Wells Fargo has been updated United Therapeutics (UTHR) from “Equal Weight” to “Overweight” with a price target of $735 (previously $575). The company says Ralinepag DPI provides long-term confidence in United Therapeutics’ competitive position in pulmonary indications.
JPMorgan has upgraded fresh animal (FRPT) from Neutral to Overweight with a price target of $68 (previously $66). The company expects Freshpet’s revenue and EBITDA growth to be above its consumer staples competitors and believes the stock’s current valuation does not adequately reflect this.
Arete has been updated oracle (ORCL) to Buy at Neutral with a price target of $255. The company says supply shortages are helping the economics of graphics processors.
Barclays has received an upgrade SiTime (SITM) from Equal Weight to Overweight with a price target of $850, higher than…
